- Home
- ACR vs MIST Comparison
ACR vs MIST Comparison
Compare ACR & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACR
- MIST
- Stock Information
- Founded
- ACR 2005
- MIST 2003
- Country
- ACR United States
- MIST Canada
- Employees
- ACR N/A
- MIST N/A
- Industry
- ACR Real Estate Investment Trusts
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ACR Real Estate
- MIST Health Care
- Exchange
- ACR Nasdaq
- MIST Nasdaq
- Market Cap
- ACR 139.0M
- MIST 145.3M
- IPO Year
- ACR N/A
- MIST N/A
- Fundamental
- Price
- ACR $20.75
- MIST $1.96
- Analyst Decision
- ACR Buy
- MIST Strong Buy
- Analyst Count
- ACR 3
- MIST 3
- Target Price
- ACR $20.50
- MIST $6.33
- AVG Volume (30 Days)
- ACR 17.7K
- MIST 1.2M
- Earning Date
- ACR 10-29-2025
- MIST 11-11-2025
- Dividend Yield
- ACR N/A
- MIST N/A
- EPS Growth
- ACR N/A
- MIST N/A
- EPS
- ACR 0.04
- MIST N/A
- Revenue
- ACR $86,599,000.00
- MIST N/A
- Revenue This Year
- ACR $10.76
- MIST N/A
- Revenue Next Year
- ACR N/A
- MIST N/A
- P/E Ratio
- ACR $505.92
- MIST N/A
- Revenue Growth
- ACR 12.74
- MIST N/A
- 52 Week Low
- ACR $14.87
- MIST $0.63
- 52 Week High
- ACR $23.81
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- ACR 55.76
- MIST 66.84
- Support Level
- ACR $20.47
- MIST $1.75
- Resistance Level
- ACR $21.21
- MIST $1.83
- Average True Range (ATR)
- ACR 0.36
- MIST 0.09
- MACD
- ACR -0.08
- MIST 0.01
- Stochastic Oscillator
- ACR 29.47
- MIST 90.91
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).